Home > Publications database > Establishing experimental therapeutic modalities and CRISPR/Cas9 screening platforms to interrogate vulnerabilities in pediatric high-grade glioma (pHGG)
 
Dissertation / PhD Thesis DKFZ-2025-02689
http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Establishing experimental therapeutic modalities and CRISPR/Cas9 screening platforms to interrogate vulnerabilities in pediatric high-grade glioma (pHGG)



2025

Dissertation, Ruprecht-Karls-University Heidelberg, 2025  GO


Note: Dissertation, Ruprecht-Karls-University Heidelberg, 2025
Contributing Institute(s):
  1. B062 Pädiatrische Neuroonkologie (B062)
  2. Pädiatrische Gliomforschung (B360)
Research Program(s):
  1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2025
Click to display QR Code for this record

The record appears in these collections:
Document types > Theses > Ph.D. Theses
Public records
Publications database
 Record created 2025-12-03, last modified 2025-12-04
Similar records



Rate this document:

Rate this document:
1
2
3
4
5
 
(Not yet reviewed)
DKFZ :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.7 | join2_v2509
Maintained by zb.invenio@dkfz-heidelberg.de

Impressum | Data Privacy Policy